TRILLIUM THERAPEUTICS INC. Earnings Per Share, Basic and Diluted
TRILLIUM THERAPEUTICS INC. reported Earnings Per Share, Basic and Diluted of -$0.18 per share for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-11-12
- TRILLIUM THERAPEUTICS INC. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.18.
- TRILLIUM THERAPEUTICS INC. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.18.
- TRILLIUM THERAPEUTICS INC. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.11.
- TRILLIUM THERAPEUTICS INC. earnings per share, basic and diluted for the quarter ending 2020-12-31 was -$0.07.
- TRILLIUM THERAPEUTICS INC. earnings per share, basic and diluted for fiscal 2020 was -$0.70.
- TRILLIUM THERAPEUTICS INC. earnings per share, basic and diluted for fiscal 2019 was -$1.15.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-09-30 | -$0.18 10-Q · filed 2021-11-12 | -$0.36 derived: net income ÷ weighted average shares · filed 2021-11-12 | -$0.47 10-Q · filed 2021-11-12 | -$0.54 derived: net income ÷ weighted average shares · filed 2021-11-12 |
| 2021-06-30 | -$0.18 10-Q · filed 2021-08-13 | -$0.28 10-Q · filed 2021-08-13 | -$0.36 derived: net income ÷ weighted average shares · filed 2021-11-12 | -$0.50 derived: net income ÷ weighted average shares · filed 2021-11-12 |
| 2021-03-31 | -$0.11 10-Q · filed 2021-05-07 | -$0.18 derived: net income ÷ weighted average shares · filed 2021-11-12 | -$0.32 derived: net income ÷ weighted average shares · filed 2021-11-12 | -$0.57 derived: net income ÷ weighted average shares · filed 2021-11-12 |
| 2020-12-31 | -$0.07 derived: net income ÷ weighted average shares · filed 2021-03-18 | -$0.21 derived: net income ÷ weighted average shares · filed 2021-11-12 | -$0.47 derived: net income ÷ weighted average shares · filed 2021-11-12 | -$0.70 10-K · filed 2021-03-18 |
| 2020-09-30 | -$0.14 10-Q · filed 2021-11-12 | -$0.42 derived: net income ÷ weighted average shares · filed 2021-11-12 | -$0.66 10-Q · filed 2021-11-12 | |
| 2020-06-30 | -$0.28 10-Q · filed 2021-08-13 | -$0.53 10-Q · filed 2021-08-13 | ||
| 2020-03-31 | -$0.25 10-Q · filed 2021-05-07 | |||
| 2019-12-31 | -$1.15 10-K · filed 2021-03-18 |